The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, February 07, 2019
Dr. Reddy’s Laboratories announced it is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram Sodium Chloride Injection single-...
read more
Thursday, February 07, 2019
AIVITA Biomedical announced findings which indicate a mechanism of action for its ROOT OF CANCER technology.
read more
Tuesday, February 12, 2019
Janssen Research & Development
Janssen Pharmaceutical announced the FDA has approved a split-dosing regimen for DARZALEX, providing healthcare professionals and patients with ...
read more
Wednesday, February 13, 2019
Mylan announced the launch of the first FDA-approved therapeutically equivalent, substitutable generic of ADVAIR DISKUS, Wixela Inhub, approved by the...
read more
Friday, February 15, 2019
The FDA permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology for delivering insulin under the skin for...
read more
Thursday, February 21, 2019
Indivior has launched an authorized generic version of SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) in the U.S.
read more
Tuesday, February 26, 2019
ROMEG Therapeutics announced the FDA approved GLOPERBA (colchicine) Oral Solution, 0.6 mg/5 mL for prophylaxis of gout flares in adults.
read more
Wednesday, February 27, 2019
Heron Therapeutics announced the FDA has approved Heron's sNDA for CINVANTI (aprepitant) injectable emulsion, for intravenous use.
read more
Wednesday, February 27, 2019
Janssen Research & Development
Janssen Pharmaceutical announced the FDA has approved TREMFYA® One-Press, a single-dose, patient-controlled injector for adults with moderate-to-...
read more
Wednesday, February 27, 2019
IBSA Pharma announced its Tirosint-SOL (levothyroxine sodium) oral solution is now available in the US market for the treatment of hypothyroidism and ...
read more
Thursday, February 28, 2019
ICU Medical has announced a voluntary recall of certain lots of ChemoLock™ and ChemoClave® Vial Spikes due to the potential for burr particulate ...
read more
Thursday, February 28, 2019
The first human study of a pill designed to replace injections of biologics is today being announced by Rani Therapeutics, the inventor of the ...
read more
Novo Nordisk announced it recently submitted label updates to the EMA and the FDA for Fiasp® 100 u/mL, seeking approval for use as a new mealtime ...
read more
Eli Lilly and Company announced the company will introduce a lower-priced version of Humalog® (insulin lispro injection 100 units/mL) in the United ...
read more
Wednesday, March 06, 2019
The FDA has approved Spravato nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have treatment-...
read more